Just looking at the IC50 for Monepantel which is 25 micromolars and rapamycin the IC50 is 0.1nm
It seems weird Monepantel is x250 less potent than rapamycin and would even show any signs of improvement.
Am I missing something or is there another mechanism of action that makes Monepantel effective?
Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-159
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $20.93K | 102.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36959 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 71032 | 2 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |